161 related articles for article (PubMed ID: 34850965)
1. CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.
Li F; Zhang L; Sun Q
Histol Histopathol; 2022 Mar; 37(3):227-241. PubMed ID: 34850965
[TBL] [Abstract][Full Text] [Related]
2. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
Yang L; Wang L; Wu J; Wang Y
Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
[TBL] [Abstract][Full Text] [Related]
3. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
Luo H; Peng J; Yuan Y
Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Wang J; Yang K; Cao J; Li L
Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
[TBL] [Abstract][Full Text] [Related]
5. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
[TBL] [Abstract][Full Text] [Related]
7. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
[TBL] [Abstract][Full Text] [Related]
8. Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
Cai Y; Dong Z; Wang J
World J Surg Oncol; 2022 Oct; 20(1):329. PubMed ID: 36192755
[TBL] [Abstract][Full Text] [Related]
9. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
[TBL] [Abstract][Full Text] [Related]
10. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
12. Circ_0011058 facilitates proliferation, angiogenesis and radioresistance in papillary thyroid cancer cells by positively regulating YAP1 via acting as miR-335-5p sponge.
Zhang Z; Wang W; Su Z; Zhang J; Cao H
Cell Signal; 2021 Dec; 88():110155. PubMed ID: 34562605
[TBL] [Abstract][Full Text] [Related]
13. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity.
Xu Y; Jiang T; Wu C; Zhang Y
Biotechnol Lett; 2020 Jul; 42(7):1123-1135. PubMed ID: 32170433
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p.
Zang HL; Ji FJ; Ju HY; Tian XF
World J Gastroenterol; 2021 Jan; 27(3):240-254. PubMed ID: 33519139
[TBL] [Abstract][Full Text] [Related]
15. Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p/GLS axis.
Lu R; Zhang X; Li X; Wan X
Int J Clin Exp Pathol; 2020; 13(7):1791-1801. PubMed ID: 32782707
[TBL] [Abstract][Full Text] [Related]
16. CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
Dong X; Chen X; Zhao Y; Wu Q; Ren Y
J Gastroenterol Hepatol; 2024 Jan; 39(1):121-132. PubMed ID: 38037531
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis.
Liu Y; Li H; Ye X; Ji A; Fu X; Wu H; Zeng X
World J Surg Oncol; 2020 Sep; 18(1):255. PubMed ID: 32993655
[TBL] [Abstract][Full Text] [Related]
19. Circ_0067717 promotes colorectal cancer cell growth, invasion and glutamine metabolism by serving as a miR-497-5p sponge to upregulate SLC7A5.
Song M; Liu J
Histol Histopathol; 2023 Jan; 38(1):53-64. PubMed ID: 35818779
[TBL] [Abstract][Full Text] [Related]
20. Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5.
Chang Z; Fu Y; Jia Y; Gao M; Song L; Zhang W; Zhao R; Qin Y
Cancer Cell Int; 2021 Sep; 21(1):495. PubMed ID: 34530825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
